Sprycel Copay Card and Patient Financial Assistance Programs

If you're taking Sprycel, you're likely familiar with the financial burden it can bring. Sprycel copay cards can help alleviate some of this stress.

To be eligible for a Sprycel copay card, you must have commercial insurance, have a valid prescription, and meet certain income requirements.

The Sprycel copay card can help reduce your out-of-pocket costs to as little as $0 per month for your medication.

The list price for Sprycel is $18,246 per month, but most patients pay less.

If you have commercial insurance, you may be eligible for the Sprycel co-pay program, which can reduce your monthly payment to $0.

Commercially insured patients who qualify for the co-pay program may pay as little as $0 per month, but this depends on their insurance coverage and income level.

Medicare patients may pay $0 to $3,450 per month for Sprycel, with 75% paying $25 or less.

If you have Medicaid, you may pay $0 to $20 per month for Sprycel, and you can visit the Medicaid website to find out if you qualify.

Recommended read: What Is Copay Assistance Program

If you don't have insurance coverage, you may pay the list price, but you can call Bristol Myers Squibb Access Support at 1-800-861-0048 to explore your coverage options.

Here are the possible monthly payments for Sprycel based on insurance status:

If you're struggling to pay for your Sprycel medication, there are several patient assistance programs available to help. You can enroll in the BMS Access Support Co-Pay Assistance Program if you have commercial insurance and are prescribed select BMS medications.

To qualify for the NowPatient SPRYCEL savings programs, you'll need to create a free account and complete an eligibility quiz. Each program has its own eligibility requirements, and the table below shows which programs are available to you based on your insurance status.

If you're a Medicare patient and the SPRYCEL drug savings options aren't applicable to you, you can check Medicaid eligibility in your state through HealthCare.gov. The Patient Access Network Foundation (PAN) may also be able to assist you if you meet certain criteria, such as having an income below 400% of the federal poverty level or receiving treatment in the United States.

If you have commercial insurance, you may be eligible for the BMS Access Support Co-Pay Assistance Program, which helps with out-of-pocket deductibles, co-pays, or co-insurance requirements.

This program is specifically designed for patients who have been prescribed select BMS medications and are commercially insured.

Patients under 65 years old or those with private insurance plans can find patient assistance or copay assistance for Dasatinib (Sprycel) through links provided on the Patient Assistance page.

Depending on your income, these programs may be able to help cover the cost of branded medications, and in some cases, generic medications too.

If you're uninsured, check with the manufacturer to see if you're eligible to receive medication at no cost.

Medicare and Medicaid patients, or those 65 years or older, should ask their clinic or hospital for help understanding drug costs, as they will likely pre-authorize medications and immune therapies like Dasatinib (Sprycel).

To get started, ask to speak with a patient assistance technician or financial counselor at the clinic or hospital administering this therapy.

Here are some specific resources to consider:

The NowPatient drug savings programs are suitable for brand and generic versions of SPRYCEL, but only the Rx Advantage Card and Canadian Prescription Savings programs cover generic versions.

If you're insured with Medicare, you may still be eligible for these programs, but it's essential to check the specifics of each program.

The SPRYCEL Drug Coupon and SPRYCEL Patient Assistance Program are only available for brand versions of the medication, and only if offered by the pharmaceutical company.

If you're struggling to pay for SPRYCEL due to unaffordable copays or deductibles, you may be eligible for assistance from the Patient Access Network Foundation (PAN), the HealthWell Foundation Copay Program, or the Patient Advocate Foundation Co-Pay Relief Program.

To qualify for PAN assistance, you'll need to meet one or more of the following criteria: your income is below 400% of the federal poverty level, SPRYCEL is prescribed for an approved FDA indication, you live in the United States or U.S. territories, you have Medicare insurance coverage that covers SPRYCEL, or SPRYCEL is listed on PAN's list of covered medications.

Take a look at this: Rinvoq Ruxience Copay Savings Card

You can check the HealthWell Foundation Website for more information on their copay program, which requires you to live in and be treated in the United States, be insured, and have a plan that covers SPRYCEL.

The Patient Advocate Foundation Co-Pay Relief program is another option, which requires you to have a confirmed diagnosis and treatment plan, reside and receive treatment in the United States, and meet income requirements that fall at or below 300% or 400% of the Federal Poverty Guideline.

Here's a summary of the eligibility criteria for each program:

Your doctor may advise to interrupt dasatinib therapy for a short period of time if your blood test results show a need for it.

Depending on the results, your doctor may adjust your treatment plan. If your blood cells are too low, they may decrease the dose of dasatinib therapy.

Before starting treatment, your doctor will likely discuss your treatment options with you. During treatment, they may monitor your blood test results to see how your body is responding to the medication.

If your blood test results show that the medication is not working effectively, your doctor may switch your therapy.